Dublin-based drug maker Shire revised its earnings guidance after record sales growth, only a week after U.S. peer AbbVie pulled out of a $54 billion takeover.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 10/24/2014 - 4:58am
Dublin-based drug maker Shire revised its earnings guidance after record sales growth, only a week after U.S. peer AbbVie pulled out of a $54 billion takeover.